Corporate Responsibility Report 2008
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Annual Report 2012
BRINGING How we have performed KNOWLEDGE FIN ANCIAL HIGHLIGHTS • Record adjusted diluted EPS up 7.7% to 40.7p (2011: 37.8p), ahead of market expectations TO LIFE • Full year dividend increased by 10.1% – second interim dividend of 12.5p giving a total 2012 dividend of 18.5p (2011: 16.8p) Businesses, professionals and • Revenue broadly flat despite Robbins Gioia and European academics worldwide turn to Informa Conference disposals – £1.23bn (2011: £1.28bn) for unparalleled knowledge, up-to- • Adjusted operating profit up 4.0% to £349.7m the minute information and highly (2011: £336.2m); organic growth of 2.8% specialist skills and services. • Record adjusted operating margin of 28.4% (2011: 26.4%) Our ability to deliver high quality • Adjusted profit before tax of £317.4m up 7.3% (2011: £295.9m) knowledge and services through • Statutory profit after tax of £90.7m (2011: £74.3m) multiple channels, in dynamic and rapidly changing environments, • Strong cash generation – operating cash flow up 5.7% to £329.0m (2011: £311.2m) makes our offer unique and • Balance sheet strength maintained – net debt/EBITDA extremely valuable to individuals ratio of 2.1 times (2011: 2.1 times) and organisations. OPEAI R T ONAL HIGHLIGHTS • Proactive portfolio management drives significant Annual Report & Financial Statements for the year ended December 31 2012 improvement in the quality of Group earnings • Total product rationalisation reduced Group revenue by 2% • Investment in new products, geo-cloning and platform development • Acquisition of MMPI and Zephyr -
RELX Group Teach-In
RELX Group Teach-In Thursday, 9th November 2017 RELX Group Teach-In Thursday, 9th November 2017 Welcome Colin Tennant Head of Investor Relations, RELX Group Opening remarks My name is Colin Tennant. I am the Head of Investor Relations at RELX Group. I have three things to do today. First is to welcome everybody. So, welcome, everybody. Second is just a little bit of housekeeping. If the fire alarm does go off during this presentation, you'll be leaving the way you came in. There will be people with fluorescent jackets to help you find the exit. Hopefully, that won't happen. And the final thing I need to do is to introduce the host for today's presentation, Chet Burchett, the Chief Executive of Reed Exhibitions, who is going to lead you through all we are going to cover for today. So, Chet over to you. Overview of Reed Exhibitions Chet Burchett Chief Executive Officer, Reed Exhibitions My Background Thank you, Colin. Good afternoon. As Colin notes, I am, indeed, Chet Burchett. I have been Chief Executive for Reed Exhibitions since 2015. I have been with the company for almost 14 years. I joined in February 2004 as President of North America. I came over from Burson-Marsteller, one of the WPP's global public relations agencies, where I had been serving as Chief Executive for their US business. Then, my role expanded for Reed to President of the Americas when I took on responsibility for our South American business which, at the time, was a small operation in Argentina and a few shows in Brazil. -
RELX Group Annual Reports and Financial Statements 2015
Annual Reports and Financial Statements 2015 Annual Reports and Financial Statements 2015 RELX Group is a world-leading provider of information and analytics for professional and business customers across industries. We help scientists make new discoveries, lawyers win cases, doctors save lives and insurance companies offer customers lower prices. We save taxpayers and consumers money by preventing fraud and help executives forge commercial relationships with their clients. In short, we enable our customers to make better decisions, get better results and be more productive. RELX PLC is a London listed holding company which owns 52.9 percent of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1 percent of RELX Group. Forward-looking statements The Reports and Financial Statements 2015 contain forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to competitive factors in the industries in which the Group operates; demand for the Group’s products and services; exchange rate fluctuations; general economic and business conditions; legislative, fiscal, tax and regulatory developments and political risks; the availability of third-party content and data; breaches of our data security systems and interruptions in our information technology systems; changes in law and legal interpretations affecting the Group’s intellectual property rights and other risks referenced from time to time in the filings of the Group with the US Securities and Exchange Commission. -
Annual Review 2005
GS2184_Review_A\W2.qxd 7/3/06 4:58 pm Page fc1 Annual Review 2005 human being Do more, feel better, live longer GS2184_Review_A\W2.qxd 9/3/06 1:28 pm Page ifc2 01 An interview with Sir Christopher Gent, Chairman, and JP Garnier, Chief Executive Officer 05 Tachi Yamada, Chairman, Research & Development, Pharmaceuticals 06 Jean Stéphenne, President and General Manager, GSK Biologicals 08 John Clarke, President, Consumer Healthcare 11 David Stout, President, Pharmaceutical Operations 14 Performance highlights 15 Business operating review 18 The Board 19 The Corporate Executive Team 20 Summary remuneration report 23 Corporate governance 24 Responsibility statements 25 Summary financial statements 26 Summary information under US GAAP 27 Shareholder information 29 Chairman and CEO’s closing letter JP Garnier (left) and Sir Christopher Gent (right) GS2184_Review_A\W2.qxd 7/3/06 5:01 pm Page 01 “Discovering important medicines, eradicating diseases, improving the quality of people’s lives and making medicines available to a greater number of people. This is what we do – and what we do matters to people.” JP Garnier, Chief Executive Officer An interview with Sir Christopher Gent, Chairman and JP Garnier, Chief Executive Officer 2005: a year of success and progress “Thanks to the efforts of our employees around the company’s pipeline is one of the largest and most world, 2005 was a very successful year for GSK,” says promising in the industry, with 149 projects in clinical JP Garnier, Chief Executive Officer. “Not only was it development (as at the end of February 2006), our best year ever from a financial standpoint, we also including 95 new chemical entities (NCEs), 29 product made substantial progress with our pipeline of line extensions (PLEs) and 25 vaccines. -
Financial Times Enterprise Tools Guide
FINANCIAL TIMES ENTERPRISE TOOLS GUIDE INTRODUCTION 1 01.1 What is Enterprise Tools? 2 01.2 Why Enterprise Tools? 3 01.3 Who is Enterprise Tools for? 3 ACCESS 4 02.1 Who can access Enterprise Tools? 5 02.2 How do you access Enterprise Tools? (Two-Factor Authentication) 5 FEATURES 10 03.1 Your Overview 12 03.2 Manage Users 14 03.3 Select Topics 17 03.4 Usage Insights 20 ABOUT & CONTACT 26 CONTENTS INTRODUCTION 1 HERE ARE THE KEY THINGS TO KNOW ABOUT ENTERPRISE TOOLS. 01.1 WHAT IS ENTERPRISE TOOLS? Enterprise Tools is a simple, secure, easy-to-use platform that enables the administrators of an organisation’s FT licence to manage users and select topics for them to follow, and review actionable usage insights. We’ve created a dedicated dashboard for each of these key features: Manage Users, Select Topics and Usage Insights. When you make the most of these, you can: Manage your FT licence - quickly and easily See an instant overview of the current status of your licence, so you’re always up to date Add or remove users and reset passwords, in an instant Share relevant content with users Share relevant, personalised content with individuals and teams, so they can make informed decisions – fast Save time and eort finding and collating content, so you can serve your organisation eectively View data on your licence usage Discover relevant, insightful metrics that bring you clarity and understanding Track usage and uptake against a wide variety of metrics Review, measure and report on return on investment – in moments 2 01.2 01.3 WHY ENTERPRISE WHO IS TOOLS? ENTERPRISE TOOLS FOR? We’re constantly gathering feedback and improving our service, to bring our customers Enterprise Tools is for anyone who has the best experience. -
In This Section
Strategic report In this section Chairman’s statement 2 CEO’s review 4 Business overview 6 The global context 8 Our business model 12 Our strategic priorities 14 How we performed 16 Risk management 18 Grow 20 Deliver 32 Simplify 44 Our financial architecture 48 Responsible business 50 Financial review 58 Strategic report Chairman’s statement Chairman’s statement To shareholders The value of the significant changes that have been made in recent years is evidenced in our performance this year “ Since Sir Andrew became It is clear from the following pages that Through the Audit & Risk Committee, we the Group made good progress against oversee the issues and challenges faced by CEO, the company has its strategy in 2013. management, and encourage the creation of an environment in which GSK can achieve The Board believes the business is seeing returned £30 billion its strategic ambitions in a responsible and the benefits of the significant changes the sustainable manner. to shareholders.” management team has driven over recent years to deliver sustainable growth, reduce risk and I have no doubt that commercial success is enhance returns to shareholders. directly linked to operating in a responsible way and which meets the changing expectations of The notably strong performance from the society. In this respect, the company continues R&D organisation in 2013 – with six major to adopt industry-leading positions on a range new product approvals in areas including of issues. respiratory disease, HIV and cancer – is critical to the longer-term prospects of the The announcement of plans during 2013 to Group. -
Voting/Poll Results
GLAXOSMITHKLINE PLC - RESULT OF AGM GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting (AGM) today, all resolutions were passed by shareholders. GlaxoSmithKline AGM Poll Results The following table shows the votes cast for each resolution: Resolution Total votes % Total votes % Total votes Votes for* against cast withheld** Adoption of Directors’ 1 Report and Financial Statements 3,713,877,875 98.86 42,764,532 1.14 3,756,642,407 9,313,386 Approval of the 2 Remuneration Report 3,528,115,173 94.55 203,482,136 5.45 3,731,597,309 34,358,483 Election of 3 Lynn Elsenhans 3,753,666,422 99.90 3,577,765 0.10 3,757,244,187 8,711,607 Election of 4 Jing Ulrich 3,753,601,642 99.90 3,623,347 0.10 3,757,224,989 8,730,805 Election of 5 Hans Wijers 3,712,833,757 98.82 44,327,830 1.18 3,757,161,587 8,794,257 Re-election of Sir 6 Christopher Gent 3,679,075,355 97.92 78,304,492 2.08 3,757,379,847 8,575,946 Re-election of 7 Sir Andrew Witty 3,753,850,300 99.90 3,750,413 0.10 3,757,600,713 8,355,081 Re-election of Professor Sir 8 Roy Anderson 3,753,929,716 99.91 3,483,857 0.09 3,757,413,573 8,542,221 Re-election of 9 Dr Stephanie Burns 3,749,134,033 99.78 8,228,665 0.22 3,757,362,698 8,592,951 Re-election of 10 Stacey Cartwright 3,735,971,985 99.43 21,360,372 0.57 3,757,332,357 8,623,292 Re-election of 11 Simon Dingemans 3,749,800,702 99.80 7,359,374 0.20 3,757,160,076 8,795,718 Re-election of 12 Judy Lewent 3,746,232,485 99.71 11,060,403 0.29 3,757,292,888 8,662,906 Re-election of 13 Sir Deryck Maughan 3,748,191,348 99.76 9,051,199 0.24 -
Research Library Page 1
Alumni - Research Library Title Citation Abstract Full_Text Pub Type Publisher Subject 100 Great Business Ideas : from Leading Companies Around the 1/1/2009- 1/1/2009- 1/1/2009- Marshall Cavendish World 1/1/2009 1/1/2009 1/1/2009 Books International (Asia) Pte Ltd BUSINESS AND ECONOMICS 100 Great Sales Ideas : from Leading Companies 1/1/2009- 1/1/2009- 1/1/2009- Marshall Cavendish Around the World 1/1/2009 1/1/2009 1/1/2009 Books International (Asia) Pte Ltd BUSINESS AND ECONOMICS 1/1/1988- 1/1/1988- INTERIOR DESIGN AND 1001 Home Ideas 6/1/1991 6/1/1991 Magazines Family Media, Inc. DECORATION 3/1/2002- 3/1/2002- Oxford Publishing 20 Century British History 7/1/2009 7/1/2009 Scholarly Journals Limited(England) HISTORY--HISTORY OF EUROPE 33 Charts [33 Charts - 12/12/2009 12/12/2009- 12/12/2009 BLOG] + 6/3/2011 + Other Resources Newstex CHILDREN AND YOUTH--ABOUT COMPUTERS--INFORMATION 50+ Digital [50+ Digital, 7/28/2009- 7/28/2009- 7/28/2009- SCIENCE AND INFORMATION LLC - BLOG] 2/22/2010 2/22/2010 2/22/2010 Other Resources Newstex THEORY IDG 1/1/1988- 1/1/1988- Communications/Peterboro COMPUTERS--PERSONAL 80 Micro 6/1/1988 6/1/1988 Magazines ugh COMPUTERS 11/24/2004 11/24/2004 11/24/2004 Australian Associated GENERAL INTEREST PERIODICALS-- AAP General News Wire + + + Wire Feeds Press Pty Limited UNITED STATES AARP Modern Maturity; 2/1/1988- 2/1/1988- 2/1/1991- American Association of [Library edition] 1/1/2003 1/1/2003 11/1/1997 Magazines Retired Persons GERONTOLOGY AND GERIATRICS American Association of AARP The Magazine 3/1/2003+ 3/1/2003+ Magazines Retired Persons GERONTOLOGY AND GERIATRICS ABA Journal 8/1/1972+ 1/1/1988+ 1/1/1992+ Scholarly Journals American Bar Association LAW ABA Journal of Labor & Employment Law 7/1/2007+ 7/1/2007+ 7/1/2007+ Scholarly Journals American Bar Association LAW MEDICAL SCIENCES--NURSES AND ABNF Journal 1/1/1999+ 1/1/1999+ 1/1/1999+ Scholarly Journals Tucker Publications, Inc. -
FINANCIAL TIMES LTD V UNITED KINGDOM
[2010] E.M.L.R. 21 533 FINANCIAL TIMES LTD v UNITED KINGDOM European Court of Human Rights (Fourth Section) Application 821/03 Judges Lech Garlicki (President), Nicholas Bratza, Giovanni Bonello, Ljiljana Mijović, David Thór Björgvinsson, Ledi Bianku, Mihai Poalelungi: November 24, 20091 [2010] E.M.L.R. 21 Disclosure orders; Financial journalism; Freedom of expression; Press; Sources of information H1 European Convention on Human Rights arts 6, 8, 10—disclosure of journalistic source—right to freedom of expression—need for flexibility in applying rule requiring exhaustion of domestic remedies—importance of protection of journalistic sources for the maintenance of a free and effective press—relevance of the conduct or motive of the source—relevance of steps taken by journalists to verify accuracy of information—no order to be made if less invasive alternative available. H2 The applicants were the Financial Times Ltd, Independent News & Media Ltd, Guardian Newspapers Ltd, Times Newspapers Ltd and Reuters Group Plc. H3 On October 30, 2001 the board of Interbrew SA, a Belgian brewing group, instructed its investment bankers, Goldman Sachs and Lazard, to carry out work on the possibility of a future acquisition by Interbrew of South African Breweries plc (“SAB”). Goldman Sachs produced a document which was confidential and contained data likely to affect the share prices of Interbrew and of SAB. The document formed the basis of a presentation to Interbrew’s internal mergers and acquisitions department on November 20, 2001. About a week later, copies of a document (“the leaked document”) were sent to each of the applicants (apart from the Independent) by an unknown source. -
Exhibitions Teach-In November 9, 2017 London
Exhibitions teach-in November 9, 2017 London 1 DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “outlook”, “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to: current and future economic, political and market forces; changes in law and legal interpretations affecting the Group’s intellectual property rights; regulatory and other changes regarding the collection, transfer or use of third party content and data; demand for the Group’s products and services; competitive factors in the industries in which the Group operates; compromises of our data security systems and interruptions in our information technology systems; legislative, fiscal, tax and regulatory developments and political risks; exchange rate fluctuations; and other risks referenced from time to time in the filings of RELX PLC and RELX NV with the US Securities and Exchange Commission. 2 1 Exhibitions overview Chet Burchett Chief Executive Officer, Exhibitions 3 -
Competitive Implications of Environmental Regulation
Competitive Implications of Environmental Regulation A Study of Six lndustries The Management Institute for Environment and Business 1101 17th Street, NW, Suite 502 Washington, DC 20036 (202) 833-6556 with the U.S. Environmental Protection Agency Printed on processed chlorine free recycled paper: This paper is manufactured without the use of chlorine or chlorine derivatives. It contains 20% post-consumer waste. CONTENTS Competitive Implications of Environmental Regulations Executive Summary ............................................ .i The Pulp and Paper Industry ...................................... .7 The Computer and Electronic Component Industry ....................... 119 The Paint and Coatings Industry ................................... 189 The Refrigerator Industry ....................................... 251 The Dry Cell Battery Industry .................................... 317 The Printing Ink Industry. ....................................... 357 DISCLAIMER Although prepared with EPA funding, this report has neither been reviewed nor approved by the U.S. Environmental Protection Agency for publication as an EPA report. The contents do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. nor does mention of trade names or commercial products constitute endorsement or recommendation for use. Executive Summary EXECUTIVE SUMMARY Competitive Implications of Environmental Regulation The following industry studies were conducted in 1993 and 1994 to examine the role that environmental regulations play in determining competitive advantage. The six industries -- paint and coatings, pulp and paper, computers and electronic components, refrigerators, batteries, and printing inks -- have three common characteristics. They are global industries, they face significant environmental challenges, and the U.S. is a leading producer. In aggregate, these industries comprise world sales of $160 billion per year. This project was a collaboration between the Management Institute for Environment and Business, Hochschule St. -
Gabby Reed, Manager State Government Affairs – Rocky Mountain Region Elsevier Lexisnexis Legal & Professional Lexisnexis Risk Solutions Reed Exhibitions
Gabby Reed, Manager State Government Affairs – Rocky Mountain Region Elsevier LexisNexis Legal & Professional LexisNexis Risk Solutions Reed Exhibitions January 7, 2021 The Honorable Dan Ruby Chairman, House Transportation Committee North Dakota State Capitol 600 East Boulevard Bismarck, ND 58505-0360 Re: HB 1098 “Relating to reporting crashes and obtaining crash reports and data” Dear Chairman Ruby: I am writing on behalf of RELX Group and LexisNexis Risk Solutions, a leader in providing essential information to help customers across industry and government assess, predict and manage risk, to respectfully request a small technical amendment to HB 1098 “Relating to reporting crashes and obtaining crash reports and data”. In section five of the bill, we request the following change: 39-08-13(5) Upon affirmation byrequest from a party to the accidentcrash, a party's legal representative, or the insurer of any party to the accident that the investigating officer's opinion is material to a determination of liabilitycrash, OR THE AGENT OF THAT INSURER and upon payment of a fee of fiveup to seven dollars, the director or investigating agency shall release a completed copy of the investigating officer's opinioncrash report to the entity requesting the information. The request must be made on an appropriatethe form approvedprescribed by the director. LexisNexis Risk Solutions is an insurance support organization. This amendment would ensure alignment of 39-08-13(5) with 39-08-13(4) which, under current law and in the proposed bill, permits agents of insurers to access exempt information in crash reports. This small change would ensure that an agent of the impacted insurer is able to access complete crash reports.